California Nanotechnologies (FRA:R14) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
California Nanotechnologies EBITDA Margin % Related Terms
California Nanotechnologies EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:R14 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, California Nanotechnologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
California Nanotechnologies EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, California Nanotechnologies's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where California Nanotechnologies's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
California Nanotechnologies (FRA:R14) has a EBITDA Margin % of -225.66% as of Nov. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on California Nanotechnologies and its competitors. According to the industry distribution chart, California Nanotechnologies ranks #1503 out of 1580 companies in the Chemicals industry, placing it in the top 95.1%.
Is California Nanotechnologies' EBITDA Margin % too high?
California Nanotechnologies' current EBITDA Margin % is -225.66%. Based on the distribution chart, California Nanotechnologies ranks #1503 out of 1580 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, California Nanotechnologies has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does California Nanotechnologies' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, California Nanotechnologies ranks #1503 out of 1580 companies for EBITDA Margin %. This places California Nanotechnologies in the lower half of its industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on California Nanotechnologies and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. California Nanotechnologies's current EBITDA Margin % is -225.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is California Nanotechnologies stock overvalued right now?
Based on GuruFocus' analysis, California Nanotechnologies (FRA:R14) is currently considered Modestly Undervalued. The stock's GF Value™ is €0.18, compared to a current price of €0.14 — trading 22.2% below its estimated fair value. The current EBITDA Margin % is -225.66%. California Nanotechnologies' overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For California Nanotechnologies (FRA:R14), the current EBITDA Margin % is -225.66% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is California Nanotechnologies (FRA:R14) Overvalued in 2026?
Based on GuruFocus' analysis, California Nanotechnologies stock appears to be undervalued.
The current stock price of €0.14 is trading 22.2% below its estimated GF Value™ of €0.18.
GuruFocus considers California Nanotechnologies to be Modestly Undervalued.
Key valuation signals for FRA:R14:
EBITDA Margin %: -225.66%
GF Value™: €0.18 vs. price of €0.14 (22.2% below fair value)
No single metric tells the full story. See the FRA:R14 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
California Nanotechnologies Corp engages in the production, and research and development of nanostructured components and materials. Its products include High-Strength Graphite Spark tooling, Plasma Sintering Tooling, Tungsten Carbide Tooling, Carbon Graphite Foil, Carbon Felt and Yarn, and others.
40GF Score
Get the complete analysis for FRA:R14
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:R14 has been successfully added to your 
